Walter is currently the CEO, Confluence Life Sciences. Wally has over 30 years of experience in pharmaceutical drug discovery and development. He joined Confluence as Chief Executive Officer in May 2011 after spending 28 years with pharmaceutical companies Searle, Pharmacia and Pfizer. Most recently, Wally served as the Vice President and Global Head for the Inflammation/Immunology Therapeutic Area at Pfizer. In his various management roles he led licensing and portfolio management teams along with line organizations that have delivered several drugs to market. Wally has published 30 full-length manuscripts and is a member of the American Thoracic Society and the American Society for Pharmacology and Experimental Therapeutics. Since joining Confluence, Wally has managed successful completion of a Series A investment, built the company to over 30 employees, and grown a profitable service division. Wally received a BS and MS in immunology from the University of Wisconsin.